| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2025 | MASS 908 Devices Inc. | Griffith Joseph H. IV81 | Chief Financial Officer | Sell | 5,000 | $7.07 | $35,338.50 | -4.9% | -25.6% | - | |
| Sep 19, 2025 | PLSE Pulse Biosciences, Inc. | Danahy Kevin Patrick85 | Chief Commercial Officer | Sell | 20,400 | $18.49 | $377,192.00 | -19.1% | -18.3% | - | |
| Sep 19, 2025 | ATEC Alphatec Holdings, Inc. | Sponsel David61 | EVP, Sales | Sell | 140,000 | $15.09 | $2,113,238.75 | -11.6% | +27.9% | - | |
| Sep 18, 2025 | WRBY Warby Parker Inc. | Gilboa David Abraham62 | Co-chief Executive Officer | Sell | 58,960 | $27.58 | $1,626,080.80 | -47.3% | -5.5% | - | |
| Sep 18, 2025 | WRBY Warby Parker Inc. | Blumenthal Neil Harris65 | Co-chief Executive Officer | Sell | 8,916 | $27.52 | $245,368.32 | -12.0% | -5.5% | - | |
| Sep 17, 2025 | IRMD Iradimed Corp | Susi Roger E.53 | CEO, President, Chairman | Sell | 5,000 | $71.27 | $356,367.24 | -0.1% | +36.9% | - | |
| Sep 17, 2025 | PLSE Pulse Biosciences, Inc. | Uecker Darrin | Chief Technology Officer | Sell | 45,000 | $16.25 | $731,200.00 | -15.5% | -12.5% | - | |
| Sep 16, 2025 | INCY Incyte Corp | Denton Sheila A. | EVP &General Counsel | Sell | 278 | $83.15 | $23,115.70 | -0.8% | +17.6% | - | |
| Sep 16, 2025 | AXGN Axogen, Inc. | Devinney Erick Wayne | Chief Innovation Officer | Sell | 1,137 | $16.29 | $18,521.73 | -0.5% | +78.0% | - | |
| Sep 15, 2025 | Rhoads Ann D47 | Director | Sell | 10,000 | $58.46 | $584,600.00 | -28.3% | +48.5% | - | ||
| Sep 15, 2025 | NVNO Envveno Medical Corp | Duhay Francis | Director | Sell | 4,900 | $0.83 | $4,067.00 | -4.8% | -65.3% | - | |
| Sep 15, 2025 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 714 | $25.61 | $18,285.54 | -0.9% | -4.5% | - | |
| Sep 15, 2025 | PLSE Pulse Biosciences, Inc. | Uecker Darrin | Chief Technology Officer | Sell | 75,000 | $14.96 | $1,121,750.00 | -16.9% | -10.2% | - | |
| Sep 12, 2025 | CNMD Conmed Corp | Farkas Charles | Director | Sell | 2,000 | $53.52 | $107,049.37 | -6.1% | -24.7% | - | |
| Sep 12, 2025 | Sriram Vandana | Chief Financial Officer | Buy | 4,150 | $4.79 | $19,878.50 | +5.0% | +57.0% | - | ||
| Sep 12, 2025 | BRKR Bruker Corp | Friend Cynthia M | Director | Sell | 3,535 | $32.25 | $113,989.96 | -16.4% | +50.0% | - | |
| Sep 12, 2025 | ATRC Atricure, Inc. | Noznesky Justin J67 | Chief Mktg &Strategy Officer | Sell | 3,000 | $36.30 | $108,900.00 | -3.4% | +18.1% | - | |
| Sep 12, 2025 | IRIX Iridex Corp | Dizon Romeo R64 | Chief Financial Officer | Buy | 1,450 | $1.36 | $1,974.50 | +1.2% | -26.5% | - | |
| Sep 11, 2025 | SERA Sera Prognostics, Inc. | Lindgardt Zhenya75 | Chief Executive Officer | Sell | 3,246 | $3.13 | $10,159.98 | -0.4% | +10.7% | - | |
| Sep 11, 2025 | GKOS Glaukos Corp | Navratil Tomas59 | Chief Development Officer | Sell | 5,142 | $88.22 | $453,620.40 | -3.3% | +24.3% | - | |
| Sep 11, 2025 | BLFS Biolife Solutions Inc | Werner Sean60 | Chief Technology Officer | Sell | 72 | $26.83 | $1,931.76 | -0.3% | -7.4% | - | |
| Sep 11, 2025 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 630 | $26.83 | $16,902.90 | -0.2% | -7.4% | - | |
| Sep 11, 2025 | SERA Sera Prognostics, Inc. | Harrison Robert Gardner74 | Chief Information Officer | Sell | 645 | $3.13 | $2,018.85 | -0.6% | +10.7% | - | |
| Sep 11, 2025 | SERA Sera Prognostics, Inc. | Boniface John J.55 | Chief Scientific Officer | Sell | 1,395 | $3.13 | $4,366.35 | -0.9% | +10.7% | - | |
| Sep 11, 2025 | SERA Sera Prognostics, Inc. | Jackson Benjamin81 | General Counsel | Sell | 934 | $3.13 | $2,923.42 | -0.7% | +10.7% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.